Patient ID,Sample ID,Cancer Study,Cancer Type,Cancer Type Detailed,Number of Samples Per Patient,Mutation Count,Fraction Genome Altered,Sex,Ethnicity Category,Sample Type,Age at Which Sequencing was Reported,Center,Oncotree Code,Primary Race,Sample Type Detailed,Sequence Assay ID
GENIE-DFCI-007106,GENIE-DFCI-007106-5905,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,5,,Female,Non-Spanish/non-Hispanic,Primary,76,DFCI,DDCHS,White,Primary tumor,DFCI-ONCOPANEL-2
GENIE-DFCI-007712,GENIE-DFCI-007712-4966,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,2,,Male,Non-Spanish/non-Hispanic,Primary,34,DFCI,DDCHS,White,Primary tumor,DFCI-ONCOPANEL-2
GENIE-DFCI-009708,GENIE-DFCI-009708-9606,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,6,,Male,Non-Spanish/non-Hispanic,Primary,78,DFCI,DDCHS,White,Primary tumor,DFCI-ONCOPANEL-2
GENIE-DFCI-048787,GENIE-DFCI-048787-203608,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,9,,Female,Non-Spanish/non-Hispanic,Primary,75,DFCI,DDCHS,White,Primary tumor,DFCI-ONCOPANEL-3
GENIE-DFCI-268803,GENIE-DFCI-268803-3530920,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,14,,Male,Non-Spanish/non-Hispanic,Primary,77,DFCI,DDCHS,White,Primary tumor,DFCI-ONCOPANEL-3.1
GENIE-MSK-P-0007301,GENIE-MSK-P-0007301-T01-IM5,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,2,0.3574,Female,Non-Spanish/non-Hispanic,Metastasis,59,MSK,DDCHS,Black,Metastasis site unspecified,MSK-IMPACT410
GENIE-MSK-P-0008266,GENIE-MSK-P-0008266-T01-IM5,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,1,0.197,Female,Spanish/Hispanic,Metastasis,55,MSK,DDCHS,White,Metastasis site unspecified,MSK-IMPACT410
GENIE-MSK-P-0011358,GENIE-MSK-P-0011358-T01-IM5,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,6,0.0943,Male,Non-Spanish/non-Hispanic,Primary,64,MSK,DDCHS,White,Primary tumor,MSK-IMPACT410
GENIE-MSK-P-0015458,GENIE-MSK-P-0015458-T01-IM6,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,2,1,0.0012,Female,Non-Spanish/non-Hispanic,Metastasis,42,MSK,DDCHS,Asian,Metastasis site unspecified,MSK-IMPACT468
GENIE-MSK-P-0021850,GENIE-MSK-P-0021850-T01-IM6,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,7,0.7838,Female,Non-Spanish/non-Hispanic,Metastasis,79,MSK,DDCHS,White,Metastasis site unspecified,MSK-IMPACT468
GENIE-MSK-P-0022676,GENIE-MSK-P-0022676-T01-IM6,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,7,0.4086,Female,Non-Spanish/non-Hispanic,Primary,72,MSK,DDCHS,White,Primary tumor,MSK-IMPACT468
GENIE-MSK-P-0028884,GENIE-MSK-P-0028884-T01-IM6,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,2,0.6367,Male,Non-Spanish/non-Hispanic,Primary,64,MSK,DDCHS,White,Primary tumor,MSK-IMPACT468
GENIE-MSK-P-0030911,GENIE-MSK-P-0030911-T01-IM6,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,1,0.1484,Female,Non-Spanish/non-Hispanic,Primary,51,MSK,DDCHS,White,Primary tumor,MSK-IMPACT468
GENIE-MSK-P-0032062,GENIE-MSK-P-0032062-T01-IM6,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,3,0.0771,Male,Non-Spanish/non-Hispanic,Primary,56,MSK,DDCHS,White,Primary tumor,MSK-IMPACT468
GENIE-MSK-P-0041093,GENIE-MSK-P-0041093-T01-IM6,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,4,0.4029,Female,Non-Spanish/non-Hispanic,Primary,60,MSK,DDCHS,White,Primary tumor,MSK-IMPACT468
GENIE-MSK-P-0042440,GENIE-MSK-P-0042440-T02-IM6,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,2,0.1619,Female,Non-Spanish/non-Hispanic,Primary,56,MSK,DDCHS,White,Primary tumor,MSK-IMPACT468
GENIE-VICC-103029,GENIE-VICC-103029-unk-1,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,3,,Male,Non-Spanish/non-Hispanic,Primary,43,VICC,DDCHS,White,Primary tumor,VICC-01-D2
GENIE-VICC-653909,GENIE-VICC-653909-unk-1,genie_public,Bone Cancer,Dedifferentiated Chondrosarcoma,1,5,,Male,Non-Spanish/non-Hispanic,Primary,62,VICC,DDCHS,White,Primary tumor,VICC-01-D2